AbbVie annual dividends paid
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
AbbVie Dividends Paid Growth & History (ABBV)
AbbVie paid $11.66B in dividends during fiscal 2025.
View full AbbVie company overviewAbbVie annual dividends paid history
| Fiscal year | Period ended | Dividends paid | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $11.66B | $632.0M | +5.73% |
| 2024 | 2024-12-31 | $11.03B | $486.0M | +4.61% |
| 2023 | 2023-12-31 | $10.54B | $496.0M | +4.94% |
| 2022 | 2022-12-31 | $10.04B | $782.0M | +8.44% |
| 2021 | 2021-12-31 | $9.26B | $1.54B | +20.02% |
| 2020 | 2020-12-31 | $7.72B | $1.35B | +21.21% |
| 2019 | 2019-12-31 | $6.37B | $786.0M | +14.09% |
| 2018 | 2018-12-31 | $5.58B | $1.47B | +35.87% |
| 2017 | 2017-12-31 | $4.11B | $390.0M | +10.49% |
| 2016 | 2016-12-31 | $3.72B | $423.0M | +12.84% |
| 2015 | 2015-12-31 | $3.29B | $633.0M | +23.79% |
| 2014 | 2014-12-31 | $2.66B | $106.0M | +4.15% |
| 2013 | 2013-12-31 | $2.56B | — | — |
AbbVie quarterly dividends paid
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q1.16
Q2.16
Q3.16
Q1.17
Q2.17
Q3.17
Q1.18
Q2.18
Q3.18
Q1.19
Q2.19
Q3.19
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Dividends paid | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $3.07B | $160.0M | +5.50% |
| Q1 2026 | 2026-03-31 | $3.09B | $161.0M | +5.50% |
| Q4 2025 | 2025-12-31 | $2.91B | $159.0M | +5.78% |
| Q3 2025 | 2025-09-30 | $2.91B | $160.0M | +5.82% |
| Q2 2025 | 2025-06-30 | $2.91B | $160.0M | +5.82% |
| Q1 2025 | 2025-03-31 | $2.92B | $153.0M | +5.52% |
| Q4 2024 | 2024-12-31 | $2.75B | — | — |
| Q3 2024 | 2024-09-30 | $2.75B | $124.0M | +4.72% |
| Q2 2024 | 2024-06-30 | $2.75B | $125.0M | +4.76% |
| Q1 2024 | 2024-03-31 | $2.77B | $111.0M | +4.17% |
| Q3 2023 · Sep 30 | 2023-09-30 | $2.63B | $123.0M | +4.91% |
| Q2 2023 · Jun 30 | 2023-06-30 | $2.63B | $118.0M | +4.71% |
| Q1 2023 · Mar 31 | 2023-03-31 | $2.66B | $135.0M | +5.34% |
| Q3 2022 · Sep 30 | 2022-09-30 | $2.50B | $189.0M | +8.16% |
| Q2 2022 · Jun 30 | 2022-06-30 | $2.51B | $197.0M | +8.53% |
| Q1 2022 · Mar 31 | 2022-03-31 | $2.53B | $204.0M | +8.79% |
| Q3 2021 · Sep 30 | 2021-09-30 | $2.31B | $215.0M | +10.24% |
| Q2 2021 · Jun 30 | 2021-06-30 | $2.31B | $558.0M | +31.85% |
| Q1 2021 · Mar 31 | 2021-03-31 | $2.32B | $559.0M | +31.71% |
| Q3 2020 · Sep 30 | 2020-09-30 | $2.10B | $509.0M | +31.99% |
| Q2 2020 · Jun 30 | 2020-06-30 | $1.75B | $160.0M | +10.05% |
| Q1 2020 · Mar 31 | 2020-03-31 | $1.76B | $175.0M | +11.02% |
| Q3 2019 · Sep 30 | 2019-09-30 | $1.59B | $130.0M | +8.90% |
| Q2 2019 · Jun 30 | 2019-06-30 | $1.59B | $61.0M | +3.98% |
| Q1 2019 · Mar 31 | 2019-03-31 | $1.59B | $451.0M | +39.67% |
| Q3 2018 · Sep 30 | 2018-09-30 | $1.46B | $435.0M | +42.40% |
| Q2 2018 · Jun 30 | 2018-06-30 | $1.53B | $507.0M | +49.51% |
| Q1 2018 · Mar 31 | 2018-03-31 | $1.14B | $110.0M | +10.71% |
| Q3 2017 · Sep 30 | 2017-09-30 | $1.03B | $93.0M | +9.97% |
| Q2 2017 · Jun 30 | 2017-06-30 | $1.02B | $97.0M | +10.46% |
| Q1 2017 · Mar 31 | 2017-03-31 | $1.03B | $103.0M | +11.15% |
| Q3 2016 · Sep 30 | 2016-09-30 | $933.0M | $83.0M | +9.76% |
| Q2 2016 · Jun 30 | 2016-06-30 | $927.0M | $109.0M | +13.33% |
| Q1 2016 · Mar 31 | 2016-03-31 | $924.0M | $138.0M | +17.56% |
| Q3 2015 · Sep 30 | 2015-09-30 | $850.0M | $177.0M | +26.30% |
| Q2 2015 · Jun 30 | 2015-06-30 | $818.0M | $145.0M | +21.55% |
| Q1 2015 · Mar 31 | 2015-03-31 | $786.0M | $145.0M | +22.62% |
| Q4 2014 | 2014-12-31 | $674.0M | $33.0M | +5.15% |
| Q3 2014 | 2014-09-30 | $673.0M | $33.0M | +5.16% |
| Q2 2014 | 2014-06-30 | $673.0M | $35.0M | +5.49% |
| Q1 2014 | 2014-03-31 | $641.0M | $5.0M | +0.79% |
| Q4 2013 | 2013-12-31 | $641.0M | — | — |
| Q3 2013 | 2013-09-30 | $640.0M | — | — |
| Q2 2013 | 2013-06-30 | $638.0M | — | — |
| Q1 2013 | 2013-03-31 | $636.0M | — | — |
AbbVie dividends paid trends
Over the last five fiscal years, AbbVie's dividends paid increased from $7.72B to $11.66B, a change of $3.94B. The latest reported quarter, Q2 2026, shows $3.07B.
About the metric
What dividends paid mean
Dividends paid are cash distributions made to shareholders. The history shows the company’s aggregate cash outflow for dividends, not the dividend per share, dividend yield, or the date an investor receives a payment.
Calculation and source
Reported cash dividends paid
TickerStat standardizes cash dividends paid to common or ordinary shareholders from official cash-flow filings. Reported zero-dividend periods remain zero and are not treated as missing data. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review AbbVie source filings ↗Community posts
AbbVie’s menstrual-migraine study meets its primary and all ranked secondary goals
AbbVie ($ABBV) reported positive Phase 3 LUNA results for atogepant in menstrual migraine. The study enrolled 468 women and evaluated treatment across three menstrual cycles. Migraine days during the assessed menstrual period fell by 1.20 d ...